ORLANDO, Fla.—A three-year follow-up of an implanted restorative neurostimulation clinical trial found ReActiv8 (Mainstay Medical) to be safe and effective, with no lead migration in patients with refractory, disabling, mechanical chronic low back pain (LBP).
These results were detailed in a poster titled “Three-year Durability of Symptom Relief with Restorative Neurostimulation for Chronic Mechanical Low Back Pain,” which was presented at the fall meeting of the American